Characterization of the Promoter Region of the Human c‐kit Proto‐oncogene

The c‐kit proto‐oncogene encodes a tyrosine kinase receptor for stem cell factor and plays a critical role in the growth and differentiation of various types of cells including hematopoietic stem cells. To investigate the mechanisms of its transcriptional regulation, we isolated the 5’flanking region of the human c‐kit gene and characterized its promoter activity in hematopoietic cells. Nucleotide sequence analysis revealed that the 1.2 kb 5’flanking region lacked a typical “TATA box,” but had a relatively high G + C content and four potential Sp1‐binding sites. Putative binding sites for AP‐2, basic helix‐loop‐helix proteins, Ets‐domain proteins, Myb and GATA‐1 were also found. Primer extension and S1 nuclease protection analyses of hematopoietic cells indicated that the major transcription start sites are 62 bp and 58 bp upstream of the translation start site. Essentially the same start sites were detected in non‐hematopoietic cells such as small cell lung carcinoma and glioblastoma: this single promoter in c‐kit is different from the multiple promoter system of c‐fms, a c‐kit‐related gene, in which at least two promoters are differently used in hematopoietic and non‐hematopoietic cells. An analysis of the c‐kit 5’flanking region using the bacterial chloramphenicol acetyltransferase gene (CAT assay) in human erythroleukemia HEL cells, which express the endogenous c‐kit mRNA at high levels, showed that a region from ‐180 to ‐22 is important for the expression of the c‐kit gene. In addition, a negative regulatory element(s) is suggested to be involved in the regulation of the c‐kit gene expression in mammals.

[1]  S. Galli,et al.  Cloning and functional analysis of the mouse c-kit promoter. , 1993, Biochemical and biophysical research communications.

[2]  R. Spritz,et al.  Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. , 1992, Oncogene.

[3]  M. Mattei,et al.  Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1 , 1992, Molecular and cellular biology.

[4]  S. Nishikawa,et al.  c-kit Gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. , 1992, Blood.

[5]  S. Orkin.  GATA-binding transcription factors in hematopoietic cells , 1992 .

[6]  C. Decastro,et al.  Cloning and structural analysis of the human c-kit gene. , 1992, Oncogene.

[7]  T. Sugimura,et al.  Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. , 1992, Oncogene.

[8]  F. Galibert,et al.  Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III. , 1992, Oncogene.

[9]  R. Ashmun,et al.  Transcription of the human colony-stimulating factor-1 receptor gene is regulated by separate tissue-specific promoters. , 1992, Blood.

[10]  I. Bernstein,et al.  Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. , 1992, Blood.

[11]  T Takahashi,et al.  Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. , 1991, Oncogene.

[12]  H. Kitayama,et al.  Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. , 1991, Blood.

[13]  N. Copeland,et al.  Embryonic RNA expression patterns of the c‐kit receptor and its cognate ligand suggest multiple functional roles in mouse development. , 1991, The EMBO journal.

[14]  L. Ashman,et al.  Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. , 1991, Blood.

[15]  L. Ashman,et al.  Monoclonal antibody YB5.B8 identifies the human c-kit protein product , 1991 .

[16]  R. Ueda,et al.  Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. , 1991, Cancer research.

[17]  H. Weintraub,et al.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. , 1990, Science.

[18]  O. Witte.  Steel locus defines new multipotent growth factor , 1990, Cell.

[19]  M. Klemsz,et al.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. , 1990, Genes & development.

[20]  K. Nocka,et al.  Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W. , 1990, The EMBO journal.

[21]  A. Reith,et al.  W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. , 1990, Genes & development.

[22]  M. Minden,et al.  The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. , 1989, Leukemia.

[23]  F. Galibert,et al.  c-kit mRNA expression in human and murine hematopoietic cell lines. , 1989, Oncogene.

[24]  A. Bernstein,et al.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.

[25]  J. Visvader,et al.  Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes , 1989, Molecular and cellular biology.

[26]  Y. Ebina,et al.  Characterization of the promoter region of the human insulin receptor gene. , 1989, Diabetes research and clinical practice.

[27]  A. E. Sippel,et al.  Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.

[28]  D. Housman,et al.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.

[29]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[30]  I. Pastan,et al.  A transcription factor active on the epidermal growth factor receptor gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y. Ebina,et al.  Characterization of the promoter region of the human insulin receptor gene. Evidence for promoter activity. , 1987, The Journal of biological chemistry.

[32]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[33]  M. Karin,et al.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP , 1987, Cell.

[34]  B. Roe,et al.  Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Robert Tjian,et al.  Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins , 1985, Nature.

[36]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[37]  Michael R. Green,et al.  Definition of a novel promoter for the major adenovirus-associated virus mRNA , 1980, Cell.

[38]  E. Russell.  Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.

[39]  I. Miyoshi,et al.  Establishment of a T-cell line from human lymphosarcoma. , 1978, Gan.